Anti-OVCA1 antibody [EPR15342] - C-terminal
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal OVCA1 antibody. C-terminal. Suitable for IP, WB and reacts with Human samples. Cited in 3 publications.
View Alternative Names
DPH2L, DPH2L1, OVCA1, DPH1, 2-(3-amino-3-carboxypropyl)histidine synthase subunit 1, Diphthamide biosynthesis protein 1, Diphtheria toxin resistance protein 1, Ovarian cancer-associated gene 1 protein, S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1
- IP
Supplier Data
Immunoprecipitation - Anti-OVCA1 antibody [EPR15342] - C-terminal (AB185960)
Western blot analysis of immunoprecipitation pellet from SKBR3 cell lysate immunoprecipitated using ab185960 at 1/50 dilution (lane 1) or PBS control (lane 2).
Secondary : Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1500 dilution.
All lanes:
Immunoprecipitation - Anti-OVCA1 antibody [EPR15342] - C-terminal (ab185960)
Predicted band size: 49 kDa
false
- WB
Supplier Data
Western blot - Anti-OVCA1 antibody [EPR15342] - C-terminal (AB185960)
All lanes:
Western blot - Anti-OVCA1 antibody [EPR15342] - C-terminal (ab185960) at 1/10000 dilution
Lane 1:
SKBR3 cell lysate at 20 µg
Lane 2:
A375 cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/10000 dilution
Predicted band size: 49 kDa
false
- WB
Supplier Data
Western blot - Anti-OVCA1 antibody [EPR15342] - C-terminal (AB185960)
All lanes:
Western blot - Anti-OVCA1 antibody [EPR15342] - C-terminal (ab185960) at 1/1000 dilution
Lane 1:
SK OV 3 cell lysate at 20 µg
Lane 2:
HeLa cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 49 kDa
false
Related conjugates and formulations (1)
-
Anti-OVCA1 antibody [EPR15342] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein plays important roles in cellular proliferation and maintenance. OVCA1 is a part of the DPH1-DPH2 complex that facilitates the modification of eukaryotic elongation factor 2 (eEF2) through diphthamide synthesis. The process of 2-[3-carboxamido-3-(trimethylammonio)propyl]histidine diphthamide biosynthesis is essential for proper cellular protein translation. OVCA1 helps regulate the diphthamide biosynthesis pathway's first step thereby impacting the eEF2’s functionality which is important for protein synthesis and cell division.
Pathways
OVCA1's activity integrates into the cellular translation machinery where it influences the diphthamide biosynthesis pathway. This pathway is important for eEF2 modulation affecting translational control within cells. Another related pathway includes OVCA1's involvement in the cell cycle control mechanisms together with proteins like DPH2 and DPH3. By facilitating the modification of eEF2 OVCA1 effectively participates in the regulation of cellular growth impacting various growth regulatory pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 15:3301 PubMed38671004
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 129:5005-5019 PubMed31437130
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cellular physiology and biochemistry : internation 44:505-514 PubMed29145210
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com